Phantom Neuro
Austin, US · Founded 2020 · Delaware corporation · 4 known investors
Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices. Its initial application is prosthetic limb control for people with upper and lower limb difference, with future uses in robotics and human augmentation.
Founders & leadership
Phantom Neuro was founded in 2020 by Connor Glass.
CG
Connor GlassinFounder
Board
DW
EM
RL
Investors · 4
Reported raises · per SEC filings
Form D private placements$15.4M disclosed across 2 rounds · 2022–2025
▶$12.1MraisedMar 2025 · 22 investors · BiotechnologyRule 506(b)
▶$12.1MraisedMar 2025 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Connor GlassExecutive Officer, Director, Promoter
- D.A. WallachDirector
- Edward MichaelDirector
- Offering amount
- $19.3M
- Amount sold
- $12.1M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3.3MraisedMar 2022 · 6 investors · BiotechnologyRule 506(b)
▶$3.3MraisedMar 2022 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Connor GlassExecutive Officer, Director
- Robert LordDirector
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Blackrock Neurotech7 shared keywordsBlackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions. It builds implantable neural interface technology for medical and research applications.
Motif Neurotech5 shared keywordsMotif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression. The company builds implantable neurotechnology for patients with mental illness and is based in Houston, Texas.
Rf Surgical5 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Orbit5 shared keywordsOrbit is developing a brain-computer interface and accompanying models that decode emotional states. The company's goal is to make emotional context available in human interactions and in the products people use. Its investors include founders and executives from companies such as Google, Apple, Microsoft, Hugging Face, Stability AI, and Dropbox.
Mintneuro4 shared keywordsMintNeuro designs purpose-built, low-power integrated circuits for neural implants, supporting functions like neural signal acquisition, stimulation, power management, and on-chip signal processing. It works with medical-device companies, research institutions, and consortia building active implantable medical devices and brain-computer interfaces for conditions such as epilepsy, Parkinson's, dementia, and depression.
Companies competing with Phantom Neuro for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Phantom Neuro do?
- Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices. Its initial application is prosthetic limb control for people with upper and lower limb difference, with future uses in robotics and human augmentation.
- Who founded Phantom Neuro?
- Phantom Neuro was founded by Connor Glass in 2020.
- Who are Phantom Neuro's investors?
- Phantom Neuro's investors include Breakout Ventures, Draper Associates, LionBird, Time BioVentures.
- How much funding has Phantom Neuro raised?
- Phantom Neuro has disclosed $15.4M raised across 2 rounds.
- Where is Phantom Neuro headquartered?
- Phantom Neuro is headquartered in Austin, US.